McClellan; William J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McClellan; William J..The latest application filed is for "bromodomain inhibitors".

Company Profile

0.17.29

McClellan; William J. - Waukegan IL
McClellan; William J - Waukegan IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bromodomain Inhibitors App 20210236508 - Wang; Le ; et al.	2021-08-05
Bromodomain Inhibitors App 20180296566 - Wang; Le ; et al.	2018-10-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ; et al.	2018-09-06
Spirocyclic Hat Inhibitors And Methods For Their Use App 20180193315 - Kesicki; Edward A. ; et al.	2018-07-12
Bromodomain inhibitors Grant 9,994,581 - Wang , et al. June 12, 2	2018-06-12
Spirocyclic Hat Inhibitors And Methods For Their Use App 20180071262 - Kesicki; Edward A. ; et al.	2018-03-15
Bromodomain Inhibitors App 20170015673 - Wang; Le ; et al.	2017-01-19
Spirocyclic Hat Inhibitors And Methods For Their Use App 20160235716 - Kesicki; Edward A. ; et al.	2016-08-18
Dihydro-pyrrolopyridinone Inhibitors App 20160237084 - Wang; Le ; et al.	2016-08-18
Bromodomain Inhibitors App 20160143916 - Wang; Le ; et al.	2016-05-26
Dihydro-pyrrolopyridinone inhibitors Grant 9,321,764 - Wang , et al. April 26, 2	2016-04-26
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,315,488 - Ding , et al. April 19, 2	2016-04-19
Bromodomain inhibitors Grant 9,296,741 - Wang , et al. March 29, 2	2016-03-29
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20160009687 - Ding; Hong ; et al.	2016-01-14
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2	2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2	2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ; et al.	2015-07-02
Dihydro-pyrrolopyridinone Inhibitors App 20140275026 - Wang; Le ; et al.	2014-09-18
Apoptosis Promoters App 20140187531 - Bruncko; Milan ; et al.	2014-07-03
Bromodomain Inhibitors App 20140162971 - WANG; Le ; et al.	2014-06-12
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ; et al.	2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ; et al.	2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ; et al.	2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ; et al.	2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ; et al.	2014-02-27
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2	2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ; et al.	2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2	2013-10-22
Apoptosis promoters Grant 8,084,607 - Bruncko , et al. December 27, 2	2011-12-27
Apoptosis promoters Grant 7,906,505 - Bruncko , et al. March 15, 2	2011-03-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ; et al.	2010-11-25
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ; et al.	2010-11-25
Apoptosis Promoters App 20100249133 - Bruncko; Milan ; et al.	2010-09-30
N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2	2010-07-13
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ; et al.	2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ; et al.	2010-06-17
Apoptosis promoters Grant 7,709,467 - Bruncko , et al. May 4, 2	2010-05-04
Apoptosis Promoters App 20080287419 - Bruncko; Milan ; et al.	2008-11-20
Apoptosis promoters Grant 7,390,799 - Bruncko , et al. June 24, 2	2008-06-24
Inhibitors of protein kinases App 20070135387 - Michaelides; Michael R. ; et al.	2007-06-14
Apoptosis promoters App 20070027135 - Bruncko; Milan ; et al.	2007-02-01
Urokinase inhibitors App 20010049374 - Steele, Andrew W. ; et al.	2001-12-06
Inhibitors of protein farnesyltransferase and squalene synthase Grant 5,631,401 - Stein , et al. May 20, 1	1997-05-20
Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives Grant 4,618,683 - DeBernardis , et al. October 21, 1	1986-10-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.